2 30/04/2023 2023-04-30 false false false false false false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2022-05-01 Sage Accounts Production 21.0 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 11252984 2022-05-01 2023-04-30 11252984 2023-04-30 11252984 2022-04-30 11252984 2021-05-01 2022-04-30 11252984 2022-04-30 11252984 2021-04-30 11252984 bus:RegisteredOffice 2022-05-01 2023-04-30 11252984 bus:LeadAgentIfApplicable 2022-05-01 2023-04-30 11252984 bus:Director1 2022-05-01 2023-04-30 11252984 bus:Director2 2022-05-01 2023-04-30 11252984 core:WithinOneYear 2023-04-30 11252984 core:WithinOneYear 2022-04-30 11252984 core:ShareCapital 2023-04-30 11252984 core:ShareCapital 2022-04-30 11252984 core:RetainedEarningsAccumulatedLosses 2023-04-30 11252984 core:RetainedEarningsAccumulatedLosses 2022-04-30 11252984 core:CostValuation core:Non-currentFinancialInstruments 2023-04-30 11252984 core:Non-currentFinancialInstruments 2023-04-30 11252984 core:Non-currentFinancialInstruments 2022-04-30 11252984 bus:Director1 2022-04-30 11252984 bus:Director1 2023-04-30 11252984 bus:Director2 2022-04-30 11252984 bus:Director2 2023-04-30 11252984 bus:Director1 2021-04-30 11252984 bus:Director1 2022-04-30 11252984 bus:Director2 2021-04-30 11252984 bus:Director2 2022-04-30 11252984 bus:Director1 2021-05-01 2022-04-30 11252984 bus:Director2 2021-05-01 2022-04-30 11252984 bus:SmallEntities 2022-05-01 2023-04-30 11252984 bus:AuditExemptWithAccountantsReport 2022-05-01 2023-04-30 11252984 bus:FullAccounts 2022-05-01 2023-04-30 11252984 bus:SmallCompaniesRegimeForAccounts 2022-05-01 2023-04-30 11252984 bus:PrivateLimitedCompanyLtd 2022-05-01 2023-04-30 11252984 core:Subsidiary1 2022-05-01 2023-04-30 11252984 core:Associate1 2022-05-01 2023-04-30 11252984 core:Subsidiary1 2023-04-30 11252984 core:Subsidiary1 2022-04-30 11252984 core:Associate1 2023-04-30 11252984 core:Associate1 2022-04-30 11252984 1 2022-05-01 2023-04-30
Company registration number: 11252984
James Connan Limited
Unaudited filleted financial statements
30 April 2023
James Connan Limited
Contents
Directors and other information
Accountants report
Statement of financial position
Notes to the financial statements
James Connan Limited
Directors and other information
Directors Dr James Connan
Mr Paul Connan
Company number 11252984
Registered office 395 Ewell Road
Tolworth
Surbiton
Surrey
KT6 7DG
Business address 395 Ewell Road
Tolworth
Surbiton
Surrey
KT6 7DG
Accountants David McQuillan & Company
Glendinning House
6 Murray Street
Belfast
BT1 6DN
Bankers Metro Bank
One Southampton Row
London
WC1B 5HA
James Connan Limited
Report to the board of directors on the preparation of the
unaudited statutory financial statements of James Connan Limited
Year ended 30 April 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of James Connan Limited for the year ended 30 April 2023 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of Chartered Accountants Ireland , we are subject to its ethical and other professional requirements which are detailed at www.charteredaccountants.ie.
This report is made solely to the board of directors of James Connan Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of James Connan Limited and state those matters that we have agreed to state to the board of directors of James Connan Limited as a body, in this report in accordance with the requirements of Chartered Accountants Ireland as detailed at www.charteredaccountants.ie. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than James Connan Limited and its board of directors as a body for our work or for this report.
It is your duty to ensure that James Connan Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of James Connan Limited. You consider that James Connan Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of James Connan Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
David McQuillan & Company
Chartered Accountants
Glendinning House
6 Murray Street
Belfast
BT1 6DN
19 January 2024
James Connan Limited
Statement of financial position
30 April 2023
2023 2022
Note £ £ £ £
Fixed assets
Investments 5 1,118,268 1,118,268
_______ _______
1,118,268 1,118,268
Current assets
Cash at bank and in hand 5 120
_______ _______
5 120
Creditors: amounts falling due
within one year 6 ( 955,571) ( 991,275)
_______ _______
Net current liabilities ( 955,566) ( 991,155)
_______ _______
Total assets less current liabilities 162,702 127,113
_______ _______
Net assets 162,702 127,113
_______ _______
Capital and reserves
Called up share capital 100 100
Profit and loss account 162,602 127,013
_______ _______
Shareholders funds 162,702 127,113
_______ _______
For the year ending 30 April 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 19 January 2024 , and are signed on behalf of the board by:
Dr James Connan
Director
Company registration number: 11252984
James Connan Limited
Notes to the financial statements
Year ended 30 April 2023
1. General information
The company is a private company limited by shares, registered in England. The address of the registered office is 395 Ewell Road, Tolworth, Surbiton, Surrey, KT6 7DG.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements have been prepared in accordance with the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.The directors have assessed that there are no material estimates and assumptions in applying the accounting policies.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Fixed asset investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2022: 2 ).
5. Investments
Shares in group undertakings and participating interests Total
£ £
Cost
At 1 May 2022 and 30 April 2023 1,118,268 1,118,268
_______ _______
Impairment
At 1 May 2022 and 30 April 2023 - -
_______ _______
Carrying amount
At 30 April 2023 1,118,268 1,118,268
_______ _______
At 30 April 2022 1,118,268 1,118,268
_______ _______
6. Creditors: amounts falling due within one year
2023 2022
£ £
Amounts owed to group undertakings and undertakings in which the company has a participating interest 374,184 374,499
Other creditors 581,387 616,776
_______ _______
955,571 991,275
_______ _______
7. Directors advances, credits and guarantees
During the year the directors entered into the following advances and credits with the company:
2023
Balance brought forward Advances /(credits) to the directors Amounts repaid Balance o/standing
£ £ £ £
Dr James Connan ( 6,930) - ( 200) ( 7,130)
Mr Paul Connan ( 15,187) - - ( 15,187)
_______ _______ _______ _______
( 22,117) - ( 200) ( 22,317)
_______ _______ _______ _______
2022
Balance brought forward Advances /(credits) to the directors Amounts repaid Balance o/standing
£ £ £ £
Dr James Connan ( 10,382) 3,452 - ( 6,930)
Mr Paul Connan ( 17,187) 2,000 - ( 15,187)
_______ _______ _______ _______
( 27,569) 5,452 - ( 22,117)
_______ _______ _______ _______
8. Related party transactions
During the year the company entered into the following transactions with related parties:
Transaction value Balance owed by/(owed to)
2023 2022 2023 2022
£ £ £ £
CHDP Limited - - ( 374,184) ( 374,499)
Paul Connan Limited - - ( 559,070) ( 594,659)
_______ _______ _______ _______
During the year the company reduced loans from CHDP Limited, a subsidiary, and from Paul Connan Limited, a company with a common shareholder and director.
9. Controlling party
The company is under the control of Dr James Connan by virtue of his shareholding.